Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ICX-RHY-013
- Development stage
- Phase 2
- Lead developer
- Intercytex
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies
- Administration
- Intradermal
01
Overview
ICX-RHY-013 is an investigational cell therapy consisting of a suspension of cultured allogeneic human dermal fibroblasts. It is administered intradermally and developed primarily for the treatment of skin disorders, with a focus on dystrophic epidermolysis bullosa (DEB). The mechanism of action involves modulation of collagen production and remodeling within the skin to promote wound healing and tissue repair. The therapy aims to enhance wound closure, reduce pain and recurrence in chronic skin erosions associated with DEB. Originally developed by Intercytex Ltd., it has also been studied for other indications such as scars (including burn scars), contractures, burns, cicatrix (scarring), and facial skin imperfections[2][3][5][6].
- Brand names
- Vavelta
- Other names
- ICX-RHY-013ICX-RHY013ICX-RHY 013VaveltaICX RHY
Beyond the preview
Go deeper on ICX-RHY-013.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ICX-RHY-013.